Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1250 of 1475 entries
View as:

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

Phase: N/A Priority: Normal
NCT ID: NCT05811416 Org: User:
Start: 06/14/23 End: 03/31/26 Due: 03/31/27

Abatacept Versus Adalimumab Head-to-Head

Phase: N/A Priority: Normal
NCT ID: NCT00929864 Org: User:
Start: 10/31/09 End: 11/30/12 Due: 11/30/13

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Phase: N/A Priority: Normal
NCT ID: NCT05552976 Org: User:
Start: 01/10/23 End: 07/25/29 Due: 07/25/30

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00002308 Org: User:
Start: - End: 11/30/91 Due: 11/30/92

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00810147 Org: User:
Start: 02/28/09 End: 06/30/10 Due: 06/30/11

Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02265744 Org: User:
Start: 11/13/14 End: 11/30/17 Due: 11/30/18

Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01413906 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)

Phase: N/A Priority: Normal
NCT ID: NCT00002028 Org: User:
Start: - End: - Due: -

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01673854 Org: User:
Start: 09/13/12 End: 05/12/15 Due: 05/12/16

A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT05644665 Org: User:
Start: 12/09/22 End: 03/07/25 Due: 03/07/26

A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03981094 Org: User:
Start: 05/10/19 End: 07/30/19 Due: 07/30/20

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03660436 Org: User:
Start: 08/14/18 End: 10/18/18 Due: 10/18/19

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00971841 Org: User:
Start: 03/31/08 End: 04/30/12 Due: 04/30/13

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity

Phase: N/A Priority: Normal
NCT ID: NCT06084598 Org: User:
Start: 10/12/23 End: 03/08/24 Due: 03/08/25

A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05432622 Org: User:
Start: 12/19/19 End: 07/11/23 Due: 07/11/24

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT03873415 Org: User:
Start: 01/25/19 End: 05/01/19 Due: 05/01/20

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00306202 Org: User:
Start: 03/31/06 End: 05/22/19 Due: 05/22/20

Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03508271 Org: User:
Start: 11/30/17 End: 11/08/18 Due: 11/08/19

A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03165422 Org: User:
Start: 03/01/17 End: 12/29/18 Due: 12/29/19

A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05320094 Org: User:
Start: 04/15/22 End: 09/11/22 Due: 09/11/23

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT04186871 Org: User:
Start: 01/07/20 End: 12/05/22 Due: 12/05/23

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01629758 Org: User:
Start: 06/30/12 End: 12/31/14 Due: 12/31/15

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01404585 Org: User:
Start: 09/30/11 End: 02/28/13 Due: 02/28/14

A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

Phase: N/A Priority: Normal
NCT ID: NCT03769558 Org: User:
Start: 07/12/16 End: 09/30/16 Due: 09/30/17

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02899299 Org: User:
Start: 11/29/16 End: 04/28/23 Due: 04/28/24